Skip to content

Tuberous Sclerosis 7 Cn229771

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder in the tuberous sclerosis complex that leads to tumor growth in multiple organs. It typically appears in childhood and requires lifelong monitoring. Management focuses on controlling symptoms and treating affected organs.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Intractable seizures

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Seizures

(neurologic)

Developmental regression

(neurologic)

Sleep disturbances

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

mTOR inhibitor therapy

mTOR inhibitors such as everolimus or sirolimus target the underlying genetic pathway driving tuberous sclerosis lesions. These medications can reduce tumor size and prevent new growths in various organs.

medication
3

Anticonvulsant therapy

Antiepileptic medications are prescribed based on seizure type and patient age to control epilepsy, which is common in tuberous sclerosis. Selection depends on specific seizure patterns and tolerability.

medication

Additional treatment options

Neurosurgical intervention

Surgical procedures including epilepsy surgery or laser ablation may be recommended for treatment-resistant seizures or progressive hydrocephalus. Pre-surgical evaluation with video-EEG monitoring is essential.

surgical

Multidisciplinary surveillance program

Regular systematic imaging and clinical assessments across multiple specialties to detect and address complications in brain, kidneys, skin, and other organs. Typically includes annual MRI and developmental screening.

monitoring

Ketogenic diet therapy

A high-fat, low-carbohydrate diet that may help control seizures in some patients with tuberous sclerosis. Requires careful planning and supervision by a metabolic specialist.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Tuberous Sclerosis 7 Cn229771?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Northrup H, Aronow ME, Bebin EM, et al. Updated International Tuberous Sclerosis Complex Consensus Group: Recommendations on Management of Epilepsy in Tuberous Sclerosis Complex. Pediatr Neurol. 2021;120:1-8.

guideline2021
2

Curatolo P, Moavero R, de Vries PJ. Neurological and Neuropsychiatric Aspects of Tuberous Sclerosis Complex. Lancet Neurol. 2020;19(7):589-602.

review2020
3

Franz DN, Belousova E, Sparagana S, et al. Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Trial. J Child Neurol. 2016;31(4):436-443.

clinical_trial2016
4

Wang S, Fallah A, Darsaklis G, et al. Efficacy of mTOR Inhibitors in Tuberous Sclerosis Complex: A Systematic Review and Meta-Analysis. Neurology. 2019;92(15):e1756-e1766.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Tuberous Sclerosis 7 Cn229771. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy